Need Assistance?
  • US & Canada:
    +
  • UK: +

Kemptide

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

Kemptide, a synthetic heptapeptide, acts as a specific substrate for cAMP-dependent protein kinase (PKA) and is shown to be a basic serine-containing heptapeptide corresponding to a sequence from pig liver pyruvate kinase.

Category
Peptide Inhibitors
Catalog number
BAT-010512
CAS number
65189-71-1
Molecular Formula
C32H61N13O9
Molecular Weight
771.91
Kemptide
IUPAC Name
2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-4-methylpentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]propanoyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]acetic acid
Synonyms
H-Leu-Arg-Arg-Ala-Ser-Leu-Gly-OH; L-leucyl-L-arginyl-L-arginyl-L-alanyl-L-seryl-L-leucyl-glycine; (5S,8S,11S,14S,17S,20S)-20-amino-14,17-bis(3-guanidinopropyl)-8-(hydroxymethyl)-5-isobutyl-11,22-dimethyl-4,7,10,13,16,19-hexaoxo-3,6,9,12,15,18-hexaazatricosan-1-oic acid
Appearance
White Lyophilized Powder
Purity
≥97% by HPLC
Density
1.43±0.1 g/cm3 (Predicted)
Sequence
LRRASLG
Storage
Store at -20°C
Solubility
Soluble in Water
InChI
InChI=1S/C32H61N13O9/c1-16(2)12-19(33)26(50)42-21(9-7-11-39-32(36)37)29(53)43-20(8-6-10-38-31(34)35)28(52)41-18(5)25(49)45-23(15-46)30(54)44-22(13-17(3)4)27(51)40-14-24(47)48/h16-23,46H,6-15,33H2,1-5H3,(H,40,51)(H,41,52)(H,42,50)(H,43,53)(H,44,54)(H,45,49)(H,47,48)(H4,34,35,38)(H4,36,37,39)/t18-,19-,20-,21-,22-,23-/m0/s1
InChI Key
WIGDGIGALMYEBW-LLINQDLYSA-N
Canonical SMILES
CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(C)C(=O)NC(CO)C(=O)NC(CC(C)C)C(=O)NCC(=O)O)N
1.Phosphorylation sites within alpha4 subunits of alpha4beta2 neuronal nicotinic receptors: a comparison of substrate specificities for cAMP-dependent protein kinase (PKA) and protein kinase C (PKC).
Wecker L;Rogers CQ Neurochem Res. 2003 Apr;28(3-4):431-6.
The present study determined whether putative phosphorylation sites within the M3/M4 cytoplasmic domain of the human alpha4 subunit of alpha4beta2 neuronal nicotinic receptors are substrates for cAMP-dependent protein kinase (PKA) or protein kinase C (PKC). Five peptides corresponding to predicted phosphorylation sequences were synthesized, and phosphorylation was compared with standard peptide substrates for each kinase, that is, Kemptide for PKA and glycogen synthase (GS) 1-8 for PKC. VRCRSRSI had the highest affinity for PKA, with a Km of 44.5 microM; Kemptide had a Km of 7.7 microM. LMKRPSVVK and KARSLSVQH were also phosphorylated by PKA, but had lower affinities of 593 microM and 2896 microM, respectively. LMKRPSVVK had the highest affinity for PKC with a Km of 182 microM; GS 1-8 had a Km of 2.1 microM. VRCRSRSI had a comparative affinity for PKC with a Km of 327 microM. PCKCTCKK was not phosphorylated by PKA, but was a substrate for PKC with a Km of 1392 microM, whereas PGPSCKSP was not phosphorylated by either kinase. Based on these findings, results suggest that Ser-362 and Ser-486 on the human alpha4 subunit may be phosphorylated by either PKA or PKC, Ser-467 is a putative PKA site, and Thr-532 represents a likely PKC substrate; Ser-421 does not appear to be phosphorylated by either kinase.
2.Membranal tyrosine protein kinase activity (but not cAMP-dependent protein kinase activity) is associated with growth of rat mammary tumors.
Sharoni Y;Radian S;Levy J FEBS Lett. 1985 Sep 9;189(1):133-6.
DMBA induced rat mammary tumors were used to study the association of tyrosine protein kinase activity with tumor growth. Pharmacological manipulations of blood prolactin level, by perphenazine and bromocriptine, were used to stimulate or arrest tumor growth, respectively. During perphenazine treatment, a 2-3-fold increase in membranal tyrosine protein kinase activity, measured with angiotensin II as substrate, preceded the 3-4-fold increase in tumor area. At the same time the cAMP-dependent protein kinase activity, measured with kemptide as substrate, did not change.
3.Fluorous-assisted metal chelate affinity extraction technique for analysis of protein kinase activity.
Hayama T;Kiyokawa E;Yoshida H;Imakyure O;Yamaguchi M;Nohta H Talanta. 2016 Aug 15;156-157:1-5. doi: 10.1016/j.talanta.2016.04.058. Epub 2016 Apr 27.
We have developed a fluorous affinity-based extraction method for measurement of protein kinase activity. In this method, a fluorescent peptide substrate was phosphorylated by a protein kinase, and the obtained phosphopeptide was selectively captured with Fe(III)-immobilized perfluoroalkyliminodiacetic acid reagent via a metal chelate affinity technique. Next, the captured phosphopeptide was selectively extracted into a fluorous solvent mixture, tetradecafluorohexane and 1H,1H,2H,2H-tridecafluoro-1-n-octanol (3:1, v/v), using the specificity of fluorous affinity (fluorophilicity). In contrast, the remained substrate peptide in the aqueous (non-fluorous) phase was easily measured fluorimetrically. Finally, the enzyme activity could be assayed by measuring the decrease in fluorescence. The feasibility of this method was demonstrated by applying the method for measurement of the activity of cAMP-dependent protein kinase (PKA) using its substrate peptide (kemptide) pre-labeled with carboxytetramethylrhodamine (TAMRA).
Online Inquiry
Verification code
Inquiry Basket